Literature DB >> 20085163

[Comorbidities between fatigue and depression in patients with colorectal cancer].

Juliano dos Santos1, Dálete Delalibera Corrêa de Faria Mota, Cibele Andrucioli de Mattos Pimenta.   

Abstract

The objective of this study was to identify and characterize the comorbidities of fatigue and depression in colorectal cancer patients. A non-probabilistic sample of 154 outpatients (53% men; mean age 49.6 +/- 11.7 years; mean education 8.9 +/- 5.4 years). Fatigue was evaluated using the Revised Piper Fatigue Scale (min:0; max:10) and depression was evaluated using the Beck Depression Inventory (BDI) (min:0; max: 63). Fatigue was identified by 76 (49.4%) patients, and was intense (total score > or =6) for 19.7%. Scores compatible with depression (BDI >20) were found in 11 (7.1%) patients. Fatigue and depression were correlated (r = 0.395, p < 0.001). Comorbidities of moderate/severe fatigue and dysphoria/depression occurred in 12.3%. Fatigue was present in all patients with depression (100%) and depression occurred in 18% of patients with fatigue. Fatigue and depression are related phenomena. Comorbidities can be deleterious to the patient. Depression had a stronger effect on the occurrence of fatigue than the effect of fatigue on depression.

Entities:  

Mesh:

Year:  2009        PMID: 20085163     DOI: 10.1590/s0080-62342009000400024

Source DB:  PubMed          Journal:  Rev Esc Enferm USP        ISSN: 0080-6234            Impact factor:   1.086


  2 in total

1.  Quality of life, pain, anxiety and depression in patients surgically treated with cancer of rectum.

Authors:  Letácio José Freire Santos; João Batista dos Santos Garcia; Jairo Sousa Pacheco; Erica Brandão de Morais Vieira; Alcione Miranda dos Santos
Journal:  Arq Bras Cir Dig       Date:  2014 Apr-Jun

2.  Assessment of depression, anxiety and fatigue in Tunisian patients in recovery from colon cancer and their impact on quality of life.

Authors:  Amal Chamsi; Faten Ezzaairi; Jihene Sahli; Imtinene Belaid; Nouha Ammar; Rym Bourigua; Makram Hochlaf; Leila Ben Fatma; Imene Chabchoub; Slim Ben Ahmed
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-06       Impact factor: 4.322

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.